proposals have been framed as issues of access and spending. If innovation incentives come up at all, it has primarily been … because pharmaceutical companies claim that reducing drug prices will threaten innovation by lowering the returns from their … patents.In fact, however, pharmaceutical access and innovation incentives are intimately related. Health insurance can change …